End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
23.2 TWD | -0.22% | -1.28% | +34.49% |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 306.7 | 277.7 | 653.6 | 1,002 | 535 | 691.2 |
Enterprise Value (EV) 1 | 86.08 | 49.56 | 618 | 890.1 | 444.1 | 652.9 |
P/E ratio | 49 x | -9.2 x | 30.8 x | 16.6 x | -10.3 x | -7.29 x |
Yield | 2.15% | - | 0.86% | 2.74% | 1.27% | - |
Capitalization / Revenue | 0.46 x | 0.53 x | 0.8 x | 0.81 x | 0.97 x | 1.78 x |
EV / Revenue | 0.13 x | 0.09 x | 0.76 x | 0.72 x | 0.8 x | 1.69 x |
EV / EBITDA | 10.6 x | -1.96 x | 19.5 x | 10.7 x | -8.81 x | -6.68 x |
EV / FCF | -1.66 x | 0.87 x | -9.56 x | 14 x | -25.5 x | -10.4 x |
FCF Yield | -60.2% | 115% | -10.5% | 7.14% | -3.92% | -9.65% |
Price to Book | 0.78 x | 0.78 x | 1.76 x | 2.33 x | 1.23 x | 1.99 x |
Nbr of stocks (in thousands) | 35,682 | 35,682 | 35,357 | 35,682 | 40,072 | 40,072 |
Reference price 2 | 8.595 | 7.782 | 18.48 | 28.08 | 13.35 | 17.25 |
Announcement Date | 4/30/19 | 4/20/20 | 4/21/21 | 3/31/22 | 3/30/23 | 3/15/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 668.6 | 528.2 | 813.5 | 1,231 | 552 | 387.4 |
EBITDA 1 | 8.111 | -25.25 | 31.65 | 83.11 | -50.38 | -97.8 |
EBIT 1 | -6.694 | -38.25 | 18.22 | 69.84 | -64.85 | -113.4 |
Operating Margin | -1% | -7.24% | 2.24% | 5.67% | -11.75% | -29.28% |
Earnings before Tax (EBT) 1 | 4.943 | -34.56 | 22.24 | 70.74 | -45.74 | -108.2 |
Net income 1 | 6.216 | -29.9 | 21.38 | 60.16 | -50.76 | -94.78 |
Net margin | 0.93% | -5.66% | 2.63% | 4.89% | -9.2% | -24.46% |
EPS 2 | 0.1755 | -0.8455 | 0.6007 | 1.692 | -1.300 | -2.365 |
Free Cash Flow 1 | -51.79 | 57.07 | -64.68 | 63.55 | -17.4 | -63.02 |
FCF margin | -7.75% | 10.8% | -7.95% | 5.16% | -3.15% | -16.27% |
FCF Conversion (EBITDA) | - | - | - | 76.47% | - | - |
FCF Conversion (Net income) | - | - | - | 105.63% | - | - |
Dividend per Share 2 | 0.1848 | - | 0.1586 | 0.7692 | 0.1700 | - |
Announcement Date | 4/30/19 | 4/20/20 | 4/21/21 | 3/31/22 | 3/30/23 | 3/15/24 |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 |
---|---|---|---|---|
Net sales 1 | - | 248.1 | 173.5 | 129.3 |
EBITDA | - | - | - | - |
EBIT 1 | - | 6.604 | -6.098 | -21.71 |
Operating Margin | - | 2.66% | -3.52% | -16.79% |
Earnings before Tax (EBT) | - | - | - | - |
Net income | 28.45 | - | - | - |
Net margin | - | - | - | - |
EPS | 0.7981 | - | - | - |
Dividend per Share | - | - | - | - |
Announcement Date | 11/12/21 | 3/31/22 | 5/12/22 | 8/12/22 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - |
Net Cash position 1 | 221 | 228 | 35.5 | 112 | 90.9 | 38.3 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow 1 | -51.8 | 57.1 | -64.7 | 63.5 | -17.4 | -63 |
ROE (net income / shareholders' equity) | 1.61% | -8.07% | 5.91% | 15.1% | -11.8% | -24.3% |
ROA (Net income/ Total Assets) | -0.67% | -4.06% | 1.6% | 5.04% | -5.05% | -10.2% |
Assets 1 | -922.1 | 736.8 | 1,338 | 1,193 | 1,006 | 929 |
Book Value Per Share 2 | 11.00 | 9.960 | 10.50 | 12.00 | 10.80 | 8.670 |
Cash Flow per Share 2 | 6.240 | 6.500 | 4.920 | 6.860 | 6.230 | 3.690 |
Capex 1 | 0.1 | 7.04 | 5.48 | 9.27 | 13.6 | 12.6 |
Capex / Sales | 0.01% | 1.33% | 0.67% | 0.75% | 2.47% | 3.25% |
Announcement Date | 4/30/19 | 4/20/20 | 4/21/21 | 3/31/22 | 3/30/23 | 3/15/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+34.49% | 28.56M | |
-21.75% | 670M | |
+3.87% | 359M | |
-16.77% | 287M | |
-21.84% | 69.68M |
- Stock Market
- Equities
- 3349 Stock
- Financials Dexin Corporation